ClinicalTrials.gov
public full text
Public Domain
The Expression Heparanase in Term and Preterm Placentas
Heparanase is an endo-β-glucuronidase that cleaves heparin-sulfate (HS) side chains of heparan sulfate proteoglycans, an integral constituent of the extra cellular matrix (ECM). This study aims to investigate the association between heparanase expression in the human placenta and preterm birth (PTB) . The investigators hypothesize that an abnormal placentation causes relative placental ischemia that induces higher rates of heparanase expression.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- An ELISA-based Assay for Measuring Heparanase Activity#983540
- CTG-basierte fetale Herzfrequenzvariabilitäts-Analyse bei Intrahepatischer Schwangerschaftscholestase#405313
- The Role of Endogenous Heparinization As an Intraoperative Predictive Marker for Postoperative ICU Admission#860605
- Heparin continuous infusion for thromboprophylaxis in pediatric liver transplant recipients.#472524
- Sonographic Parameters and Risk of Antepartum Hemorrhage in Asymptomatic Women With Placenta Previa: A Cohort Study#873140
Record · ID 830940
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive